Recombinant Human Rabies Immunoglobulin (rhRIG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant Human Rabies Immunoglobulin (rhRIG), covering 2016-01-20 to 2016-01-20. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Human Rabies Immunoglobin (rhRIG) in Combination With Rabies Vaccine for Human Use With Human Rabies Immune Globulin (HRIG) in Combination With Rabies Vaccine for Human Use in Healthy Adult Subjects. [Phase 2]